Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

Role of autophagy in the resistance to tumour necrosis factor-related apoptosis-inducing ligand-induced apoptosis in papillary and anaplastic thyroid cancer cells.

Jin SM, Jang HW, Sohn SY, Kim NK, Joung JY, Cho YY, Kim SW, Chung JH.

Endocrine. 2014 Mar;45(2):256-62. doi: 10.1007/s12020-013-9997-8. Epub 2013 Jul 3.

PMID:
23821365
3.

A human scFv antibody against TRAIL receptor 2 induces autophagic cell death in both TRAIL-sensitive and TRAIL-resistant cancer cells.

Park KJ, Lee SH, Kim TI, Lee HW, Lee CH, Kim EH, Jang JY, Choi KS, Kwon MH, Kim YS.

Cancer Res. 2007 Aug 1;67(15):7327-34.

4.

The antiapoptotic protein BAG3 is expressed in thyroid carcinomas and modulates apoptosis mediated by tumor necrosis factor-related apoptosis-inducing ligand.

Chiappetta G, Ammirante M, Basile A, Rosati A, Festa M, Monaco M, Vuttariello E, Pasquinelli R, Arra C, Zerilli M, Todaro M, Stassi G, Pezzullo L, Gentilella A, Tosco A, Pascale M, Marzullo L, Belisario MA, Turco MC, Leone A.

J Clin Endocrinol Metab. 2007 Mar;92(3):1159-63. Epub 2006 Dec 12.

PMID:
17164298
5.

Downregulation of Nrf2 by the combination of TRAIL and Valproic acid induces apoptotic cell death of TRAIL-resistant papillary thyroid cancer cells via suppression of Bcl-xL.

Cha HY, Lee BS, Chang JW, Park JK, Han JH, Kim YS, Shin YS, Byeon HK, Kim CH.

Cancer Lett. 2016 Mar 1;372(1):65-74. doi: 10.1016/j.canlet.2015.12.016. Epub 2015 Dec 22.

PMID:
26721202
6.

Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand.

Mitsiades N, Poulaki V, Tseleni-Balafouta S, Koutras DA, Stamenkovic I.

Cancer Res. 2000 Aug 1;60(15):4122-9.

7.
8.

Valproic acid sensitizes TRAIL-resistant anaplastic thyroid carcinoma cells to apoptotic cell death.

Cha HY, Lee BS, Kang S, Shin YS, Chang JW, Sung ES, Kim YS, Choi JW, Kim JH, Kim CH.

Ann Surg Oncol. 2013 Dec;20 Suppl 3:S716-24. doi: 10.1245/s10434-013-3232-y. Epub 2013 Aug 28.

PMID:
23982257
9.

Downregulation of active caspase 8 as a mechanism of acquired TRAIL resistance in mismatch repair-proficient colon carcinoma cell lines.

Van Geelen CM, Pennarun B, Ek WB, Le PT, Spierings DC, De Vries EG, De Jong S.

Int J Oncol. 2010 Oct;37(4):1031-41.

PMID:
20811726
10.

Demethylation of TMS1 gene sensitizes thyroid cancer cells to TRAIL-induced apoptosis.

Siraj AK, Hussain AR, Al-Rasheed M, Ahmed M, Bavi P, Alsobhi SA, Al-Nuaim A, Uddin S, Al-Kuraya K.

J Clin Endocrinol Metab. 2011 Jan;96(1):E215-24. doi: 10.1210/jc.2010-0790. Epub 2010 Oct 6.

PMID:
20926535
11.

Cl-IB-MECA enhances TRAIL-induced apoptosis via the modulation of NF-kappaB signalling pathway in thyroid cancer cells.

Morello S, Sorrentino R, Porta A, Forte G, Popolo A, Petrella A, Pinto A.

J Cell Physiol. 2009 Nov;221(2):378-86. doi: 10.1002/jcp.21863.

PMID:
19562684
12.

PARP inhibition restores extrinsic apoptotic sensitivity in glioblastoma.

Karpel-Massler G, Pareja F, Aimé P, Shu C, Chau L, Westhoff MA, Halatsch ME, Crary JF, Canoll P, Siegelin MD.

PLoS One. 2014 Dec 22;9(12):e114583. doi: 10.1371/journal.pone.0114583. eCollection 2014.

13.

[Overcoming acquired resistance to tumor necrosis factor-related apoptosis-inducing ligand by Bcl-XL small interfering RNA in human colon cancer].

Zhu HB, Huang XF, Hu JZ, Zhou W, Chen W, Chen LL, He C.

Zhonghua Zhong Liu Za Zhi. 2008 Apr;30(4):245-9. Chinese.

PMID:
18788624
14.

Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs.

Ganten TM, Haas TL, Sykora J, Stahl H, Sprick MR, Fas SC, Krueger A, Weigand MA, Grosse-Wilde A, Stremmel W, Krammer PH, Walczak H.

Cell Death Differ. 2004 Jul;11 Suppl 1:S86-96.

15.

Modulation of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by chemotherapy in thyroid cancer cell lines.

Park JW, Wong MG, Lobo M, Hyun WC, Duh QY, Clark OH.

Thyroid. 2003 Dec;13(12):1103-10.

PMID:
14751030
16.

Proteasome inhibitors synergize with tumor necrosis factor-related apoptosis-induced ligand to induce anaplastic thyroid carcinoma cell death.

Conticello C, Adamo L, Giuffrida R, Vicari L, Zeuner A, Eramo A, Anastasi G, Memeo L, Giuffrida D, Iannolo G, Gulisano M, De Maria R.

J Clin Endocrinol Metab. 2007 May;92(5):1938-42. Epub 2007 Feb 27.

PMID:
17327374
17.

Galectin-1 Modulates the Survival and Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Sensitivity in Human Hepatocellular Carcinoma Cells.

Li J, Sun RR, Yu ZJ, Liang H, Shen S, Kan Q.

Cancer Biother Radiopharm. 2015 Oct;30(8):336-41. doi: 10.1089/cbr.2015.1857. Epub 2015 Sep 8.

PMID:
26348206
18.

Autophagy facilitates the development of resistance to the tumor necrosis factor superfamily member TRAIL in breast cancer.

Lv S, Wang X, Zhang N, Sun M, Qi W, Li Y, Yang Q.

Int J Oncol. 2015 Mar;46(3):1286-94. doi: 10.3892/ijo.2014.2812. Epub 2014 Dec 30.

PMID:
25572822
19.

Identification of novel molecular regulators of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in breast cancer cells by RNAi screening.

Garimella SV, Gehlhaus K, Dine JL, Pitt JJ, Grandin M, Chakka S, Nau MM, Caplen NJ, Lipkowitz S.

Breast Cancer Res. 2014 Apr 17;16(2):R41. doi: 10.1186/bcr3645.

20.

R-roscovitine sensitizes anaplastic thyroid carcinoma cells to TRAIL-induced apoptosis via regulation of IKK/NF-kappaB pathway.

Festa M, Petrella A, Alfano S, Parente L.

Int J Cancer. 2009 Jun 1;124(11):2728-36. doi: 10.1002/ijc.24260.

Supplemental Content

Support Center